More than two dozen clinical researchers from Roswell Park Cancer Institute will be among the more than 30,000 cancer specialists gathered in Chicago for the American Society of Clinical Oncology 51st Annual Meeting. Several teams will be presenting the findings of Roswell Park-led research to their colleagues from around the world.

A collaborative team of researchers led by Alex A. Adjei, MD, PhD, FACP, of Roswell Park Cancer Institute will share results from the first clinical study of the anticancer effects of the novel agent entolimod at the American Society of Clinical Oncology’s 51st Annual Meeting in Chicago.

Roswell Park Cancer Institute opened a new specialty pharmacy dedicated to the prescription needs of cancer patients. The pharmacy, located on the first floor of the main hospital near the Sunflower Café, is designed to be a one-stop location providing patients with their oncology-related and supportive medications.

Andrew Hyland, PhD, Chair of the Department of Health Behavior at Roswell Park Cancer Institute (RPCI) is a featured speaker at the New York State Cancer Prevention Summit, Wednesday, May 20 from 7:30 a.m. to 4:45 p.m. in New York City.

Roswell Park Comprehensive Cancer Center has received $6.19 million in research grant funding, including a five-year, $2.01 million National Cancer Institute grant to Xuefang Cao, MD, PhD, Assistant Member in the Department of Immunology.

Kunle Odunsi, MD, PhD, Cancer Center Deputy Director, Executive Director of the Center for Immunotherapy, and Chair of the Department of Gynecologic Oncology at Roswell Park Cancer Institute (RPCI) is a featured presenter during the special consortia of the 2015 annual meeting of the New York State Stem Cell Science Program (NYSTEM), Thursday, May 14 at Rockefeller University, New York, NY.

Roswell Park Cancer Institute joined a coalition of leading public health organizations calling for inclusion of electronic cigarettes (e-cigarettes) in the New York State Clean Indoor Air Act.